Search research articles
Contact Us
Filters
Showing results (131-140 of 164) with videos related to
Page
of 17
Sort By:
Toxins
|
May 26, 2023
Neutralizing Antibody Formation with OnabotulinumtoxinA (BOTOX<sup>®</sup>) Treatment from Global Registration Studies across Multiple Indications: A Meta-Analysis
Joseph Jankovic, Jean Carruthers, Markus Naumann, et al.
Aesthetic Surgery Journal. Open Forum
|
February 20, 2025
Canada HARMONY Study: Improvements in Patient Satisfaction With Facial Appearance and Psychological Impact of Combined Aesthetic Treatment
Jason K Rivers, Vince Bertucci, Channy Muhn, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
September 9, 2025
NivobotulinumtoxinA in the Treatment of Lateral Canthal Lines Alone and With Concurrent Treatment of Glabellar Lines
Jean Carruthers, Janet C DuBois, Daniel P Friedmann, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
October 17, 2020
Forehead Line Treatment With OnabotulinumtoxinA in Subjects With Forehead and Glabellar Facial Rhytids: A Phase 3 Study
Steven Fagien, Joel L Cohen, William Coleman, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
December 18, 2015
REFINE-1, a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial With ATX-101, an Injectable Drug for Submental Fat Reduction
Derek H Jones, Jean Carruthers, John H Joseph, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
June 15, 2017
Injectable DaxibotulinumtoxinA for the Treatment of Glabellar Lines: A Phase 2, Randomized, Dose-Ranging, Double-Blind, Multicenter Comparison With OnabotulinumtoxinA and Placebo
Jean Carruthers, Nowell Solish, Shannon Humphrey, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
April 29, 2016
Bimatoprost 0.03% for the Treatment of Eyebrow Hypotrichosis
Jean Carruthers, Kenneth Beer, Alastair Carruthers, et al.
Aesthetic Surgery Journal
|
February 6, 2018
Efficacy and Safety of ATX-101 by Treatment Session: Pooled Analysis of Data From the Phase 3 REFINE Trials
Steven H Dayan, Joel Schlessinger, Kenneth Beer, et al.
JAMA Facial Plastic Surgery
|
September 16, 2016
FACE-Q Eye Module for Measuring Patient-Reported Outcomes Following Cosmetic Eye Treatments
Anne F Klassen, Stefan J Cano, James C Grotting, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
February 5, 2021
Preventing and Treating Adverse Events of Injectable Fillers: Evidence-Based Recommendations From the American Society for Dermatologic Surgery Multidisciplinary Task Force
Derek H Jones, Rebecca Fitzgerald, Sue Ellen Cox, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 164) with videos related to
Sort By:
Page
of 17
Toxins
|
May 26, 2023
Neutralizing Antibody Formation with OnabotulinumtoxinA (BOTOX<sup>®</sup>) Treatment from Global Registration Studies across Multiple Indications: A Meta-Analysis
Joseph Jankovic, Jean Carruthers, Markus Naumann, et al.
Aesthetic Surgery Journal. Open Forum
|
February 20, 2025
Canada HARMONY Study: Improvements in Patient Satisfaction With Facial Appearance and Psychological Impact of Combined Aesthetic Treatment
Jason K Rivers, Vince Bertucci, Channy Muhn, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
September 9, 2025
NivobotulinumtoxinA in the Treatment of Lateral Canthal Lines Alone and With Concurrent Treatment of Glabellar Lines
Jean Carruthers, Janet C DuBois, Daniel P Friedmann, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
October 17, 2020
Forehead Line Treatment With OnabotulinumtoxinA in Subjects With Forehead and Glabellar Facial Rhytids: A Phase 3 Study
Steven Fagien, Joel L Cohen, William Coleman, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
December 18, 2015
REFINE-1, a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial With ATX-101, an Injectable Drug for Submental Fat Reduction
Derek H Jones, Jean Carruthers, John H Joseph, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
June 15, 2017
Injectable DaxibotulinumtoxinA for the Treatment of Glabellar Lines: A Phase 2, Randomized, Dose-Ranging, Double-Blind, Multicenter Comparison With OnabotulinumtoxinA and Placebo
Jean Carruthers, Nowell Solish, Shannon Humphrey, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
April 29, 2016
Bimatoprost 0.03% for the Treatment of Eyebrow Hypotrichosis
Jean Carruthers, Kenneth Beer, Alastair Carruthers, et al.
Aesthetic Surgery Journal
|
February 6, 2018
Efficacy and Safety of ATX-101 by Treatment Session: Pooled Analysis of Data From the Phase 3 REFINE Trials
Steven H Dayan, Joel Schlessinger, Kenneth Beer, et al.
JAMA Facial Plastic Surgery
|
September 16, 2016
FACE-Q Eye Module for Measuring Patient-Reported Outcomes Following Cosmetic Eye Treatments
Anne F Klassen, Stefan J Cano, James C Grotting, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
February 5, 2021
Preventing and Treating Adverse Events of Injectable Fillers: Evidence-Based Recommendations From the American Society for Dermatologic Surgery Multidisciplinary Task Force
Derek H Jones, Rebecca Fitzgerald, Sue Ellen Cox, et al.
Page
of 17